ES2037072T3 - Suspension coadyuvante estabilizada que comprende bromuro de dimetil-dioctadecil-amonio. - Google Patents

Suspension coadyuvante estabilizada que comprende bromuro de dimetil-dioctadecil-amonio.

Info

Publication number
ES2037072T3
ES2037072T3 ES198787202523T ES87202523T ES2037072T3 ES 2037072 T3 ES2037072 T3 ES 2037072T3 ES 198787202523 T ES198787202523 T ES 198787202523T ES 87202523 T ES87202523 T ES 87202523T ES 2037072 T3 ES2037072 T3 ES 2037072T3
Authority
ES
Spain
Prior art keywords
ammonium bromide
dioctadecil
coadjuvant
stabilized
suspension including
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787202523T
Other languages
English (en)
Inventor
Lucas Alfonsus Theodorus Hilgers
Marinus Wijnand Weststrate
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duphar International Research BV
Original Assignee
Duphar International Research BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar International Research BV filed Critical Duphar International Research BV
Application granted granted Critical
Publication of ES2037072T3 publication Critical patent/ES2037072T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)

Abstract

LA INVENCION SE REFIERE A UNA SUPENSION COADYUVANTE PARA VACUNAS QUE CONTIENE BROMURO DE DIMETILDIOCTADECILAMONIO (DDA) COMO COADYUVANTE Y UN POLIMERO DE ACIDO ACRILICO SOLUBLE EN AGUA (CARBAPOL) COMO AGENTE ESTABILIZADOR.
ES198787202523T 1986-12-19 1987-12-15 Suspension coadyuvante estabilizada que comprende bromuro de dimetil-dioctadecil-amonio. Expired - Lifetime ES2037072T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8603232 1986-12-19

Publications (1)

Publication Number Publication Date
ES2037072T3 true ES2037072T3 (es) 1993-06-16

Family

ID=19849021

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787202523T Expired - Lifetime ES2037072T3 (es) 1986-12-19 1987-12-15 Suspension coadyuvante estabilizada que comprende bromuro de dimetil-dioctadecil-amonio.

Country Status (11)

Country Link
US (1) US5026546A (es)
EP (1) EP0273512B1 (es)
JP (1) JPS63165329A (es)
AT (1) ATE60999T1 (es)
DE (1) DE3768232D1 (es)
DK (1) DK661387A (es)
ES (1) ES2037072T3 (es)
GR (1) GR3001527T3 (es)
IE (1) IE60698B1 (es)
NZ (1) NZ222938A (es)
PT (1) PT86376B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69001991T2 (de) * 1989-11-16 1993-09-23 Phidea Spa Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten.
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
US6991797B2 (en) * 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US5955077A (en) * 1993-07-02 1999-09-21 Statens Seruminstitut Tuberculosis vaccine
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US6982085B2 (en) * 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US20040013685A1 (en) * 1997-11-10 2004-01-22 Peter Andersen Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
FR2814957B1 (fr) * 2000-10-06 2002-12-20 Aventis Pasteur Composition vaccinale et procede de stabilisation
EA011578B1 (ru) * 2002-08-26 2009-04-28 Пфайзер Продактс Инк. Иммуногенная композиция для защиты крупного рогатого скота от инфекций респираторной и репродуктивной систем и ее применение
US6962608B1 (en) 2002-10-01 2005-11-08 The Regents Of The University Of California Regenerable antimicrobial polymers and fibers with oxygen bleaches
WO2004064759A2 (en) 2003-01-21 2004-08-05 Chiron Corporation Use of tryptanthrin compounds for immune potentiation
WO2004087153A2 (en) 2003-03-28 2004-10-14 Chiron Corporation Use of organic compounds for immunopotentiation
CA2571421A1 (en) 2004-06-24 2006-01-05 Nicholas Valiante Compounds for immunopotentiation
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
US7749520B2 (en) * 2004-07-07 2010-07-06 Statens Serum Institut Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
ITBO20050363A1 (it) * 2005-05-26 2006-11-27 Maccaferri Spa Off Elemento leggero di protezione filtro del tipo a materasso
CA2646891A1 (en) * 2006-03-23 2007-09-27 Novartis Ag Immunopotentiating compounds
EP2010530A2 (en) * 2006-03-23 2009-01-07 Novartis AG Methods for the preparation of imidazole-containing compounds
ATE539079T1 (de) 2006-03-23 2012-01-15 Novartis Ag Imidazochinoxalinverbindungen als immunmodulatoren
CL2008001806A1 (es) * 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
ES2569907T3 (es) 2008-06-27 2016-05-13 Zoetis Services Llc Composiciones adyuvantes novedosas
UY32306A (es) 2008-12-09 2010-07-30 Gilead Sciences Inc Derivados de pteridinona y pirimidinodiazepinona y composiciones farmacéuticas que modulan en forma selectiva los receptores tipo toll, métodos y usos
KR20200039025A (ko) 2013-09-19 2020-04-14 조에티스 서비시즈 엘엘씨 유성 아쥬반트
WO2016001907A1 (en) 2014-07-02 2016-01-07 Prendergast Patrick T Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
MX391930B (es) 2015-01-16 2025-03-21 Zoetis Services Llc Vacuna contra la fiebre aftosa.
EP3801628A1 (en) * 2018-06-04 2021-04-14 Apros Therapeutics, Inc. Tlr7 peptide conjugates
BR112020026989A2 (pt) 2018-07-02 2021-03-30 Ayuvis Research, Inc. Novas pequenas moléculas de imunomodulação

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919411A (en) * 1972-01-31 1975-11-11 Bayvet Corp Injectable adjuvant and compositions including such adjuvant

Also Published As

Publication number Publication date
IE60698B1 (en) 1994-08-10
PT86376A (en) 1988-01-01
GR3001527T3 (en) 1992-11-23
PT86376B (pt) 1990-11-20
DK661387D0 (da) 1987-12-16
IE873407L (en) 1988-06-19
DK661387A (da) 1988-06-20
DE3768232D1 (de) 1991-04-04
NZ222938A (en) 1990-11-27
JPS63165329A (ja) 1988-07-08
EP0273512A3 (en) 1988-07-27
ATE60999T1 (de) 1991-03-15
US5026546A (en) 1991-06-25
EP0273512B1 (en) 1991-02-27
EP0273512A2 (en) 1988-07-06

Similar Documents

Publication Publication Date Title
DE3768232D1 (de) Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension.
PT625053E (pt) Vacina a base de urease contra a infeccao por helicobacter
DE3751811D1 (de) LH-RH-Analoga enthaltende Formulierungen
DE69215355D1 (de) Stabilisierter Varizella-Lebendimpfstoff
DK0584692T3 (da) Vaske- og konditioneringsmiddel til hår, hud samt tekstiler og hårde overflader
DE69425948D1 (de) Zusammensetzung mit verbesserter Wasserlöslichkeit, enthaltend eine Wasserunlösliche oder an Wasser schwerunlösliche Verbindung
DK63388A (da) Isocyanomethylforbindelse samt fremgangsmaade til fremstilling af et oxadiazolimidazobenzodiazepinderivat
FI873083A0 (fi) Foerfarande foer odling av bordetella pertussis, kikhostatoxoid och kikhostavaccin.
DE69323130D1 (de) Avirulenter Tollwut-Impfstoff
PT80740A (fr) Procede de preparation d'une composition de mouillage a base de fluorochlorohydrocarbure de tensioactif et d'acide carboxyli que
ATE55110T1 (de) Verfahren zur herstellung von n-alkylsubstituierten hydroxylammoniumchloriden.
AU566243B2 (en) Optically active imidazolylpropanols
DK52783A (da) Vaccine indeholdende en ozon-inaktiveret mikroorganisme og fremgangsmaade til fremstilling af en saadan vaccine
FI855057A7 (fi) Öljyadjuvanssin sisältävä rokote sekä sen valmistusmenetelmä.
ES8203368A1 (es) Procedimiento de producir amidas ciclicas
ES515094A0 (es) Procedimiento para preparar derivados fluorados de diaminohepteno o -heptina.
AU591793B2 (en) Thionophosphonic acid esters
ES2034070T3 (es) Ester del acido tionofosfonico.
DK27081A (da) Indan-4-yl-n-alkyl-carbaminsyreestere,fremgangsmaade til fremstilling heraf samt deres anvendelse som fungicider
DE69100251D1 (de) Nagellackentferner.
ES2062044T3 (es) Un procedimiento para preparar un derivado de 2-oxoimidazolidina opticamente activo.
PT81690B (pt) Processo para preparacao de novos 13 alfa-alquil-17 beta-(3-aciloxipropil)-esteroides e de composicoes farmaceuticas que os contem
SU1205522A1 (ru) 2,4,6-три-трет.бутил-2,5-циклогексадиенон-ил-4-(1,1-диэтокси-1-этил)перокс ид в качестве инициатора свободнорадикальных превращений алкилортоформиатов
BG28980A3 (bg) Нематоцидно средство

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 273512

Country of ref document: ES